Gsk Share Discussion Threads

[montyhedge] 04/8/2017 10:06

Even the best companies bought at the wrong price is a bad investment. Its still to high.

[ny boy] 03/8/2017 19:41

Best of luck Toffeeman

[toffeeman] 03/8/2017 14:08

Back to 1715 would be nice so I can short again!

[ny boy] 03/8/2017 14:03

Quickly back to 1715p

Ridiculously cheap, I've been accumulating now holding £50k's worth, as I love the yield & quarterly divis.

[essentialinvestor] 03/8/2017 13:54

You beat me to it, was just about to make the same comment!.

[alphorn] 03/8/2017 12:44

GSK getting a boost by the fall in GBP just now following Carney's conference.

A note worth making is that for overseas investors much of the share price movement is not real. It just counter balances the value of a basket of currencies. The only time it can be real is to leverage sterling, ie. without investing using GBP funds, use borrowed GBP.

[badtime] 03/8/2017 09:59

EI ..that's what I was thinking until I saw the share price Anyway ta for replies :)

[tradermichael] 03/8/2017 09:47

But it does come around quickly!

[essentialinvestor] 03/8/2017 09:42

Thought it was today for some reason, memory not
quite what it once was.

[andyadvfn1] 03/8/2017 09:41

For the lazy ...10 august

[tradermichael] 03/8/2017 09:41

19p .......;0)

[action] 03/8/2017 09:40

Exd 10.8.17

[badtime] 03/8/2017 09:13

Excuse laziness but wens ex div

[hosede] 02/8/2017 16:51

Trader
I was thinking much more of the hospitals, doctors and surgeons - among whom I suspect a lot of quacks may well be hidden

[romeike] 02/8/2017 14:04

It's worth pointing out that GSK covering its dividend has been questioned over and over for years now and each year GSK has stuck to its plan and is probably the most reliable dividend payer on the FTSE.

I'd also point out that actually a high proportion of investors holding GSK would NOT be disappointed in a reduced divided IF Emma sets out how she is investing the cash saved. Personally I think the current freeze is likely to continue as they've already stated their ongoing policy on this - it will stay at the current level, unless an increase can be justified on improved performance. Seems perfectly sensible to me.

I would not be surprised if Emma opts to buy out Novartis share in Consumer and then spins off Consumer as it's own company.

[essentialinvestor] 02/8/2017 08:35

US hospital and test charge inflation is behind much of the
recent medical cost inflation stateside.
Posted some stats previously.

Pharma is a much easier target in the blame game than faceless hospital
groups.

[tradermichael] 02/8/2017 08:27

hosede: Not sure what you mean by 'the whole medical profession', but certainly I don't think that 'obscene profits' applies to the pharmaceutical industry, in view of the following:

1. Drug development is highly resource-intensive and expensive with only one in 5,000 drug candidates making it all the way through from discovery phase to licensing approval and onto the market.

2. Drugs typically take 12 years from the initial discovery stage to reach the market, and while estimates of costs vary, the Association of the British Pharmaceutical Industry puts it at $2.6 billion per drug. The new wave of biological drugs are even more costly.

3. 'Profitable' return is further restricted as patents only protect drugs from copycat versions for 20 years after the drug is invented. This is a bitter pill for pharmaceutical companies because it can take eight years or more after invention to accumulate enough data to get a drug past the U.S. Food and Drug Administration.

[shares and stock markets] 01/8/2017 23:05

I'm in GSK from 1487, been holding since April 2016

[hosede] 01/8/2017 18:18

Isn't the real problem with US healthcare that the whole medical profession makes obscene profits?
And isn't the DOW still rising because WTF else is there to invest in?

[dr biotech] 01/8/2017 16:14

And the republicans have control of the house too - so no excuses. Trump promised to provide better healthcare for all at lower cost, just a shyster like Corbyn. Can promise what you like till you have to actually do it.

I'm still in here - did sell some down a while ago about 30% at 1650ish from memory. GSK was my biggest holding, but is now about 4%. So significant, but not crucial.

[mj19] 01/8/2017 16:09

This is very goodhttps://www.acast.com/investorschronicle/icquestions-canshell-gskandastrakeeptheirdividends-

[mj19] 01/8/2017 16:08

Investor chronicle talks about gsk.https://www.investorschronicle.co.uk/shares/2017/07/14/glaxosmithkline-struggling-to-even-stand-still/

[essentialinvestor] 01/8/2017 14:03

Expected some market downside May,June which never came.
Now in to August and still no sign, I can live in hope ).